NASDAQ · ENLV
Enlivex Ltd.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ENLV: Nov 13, 2026
Enlivex Ltd. Ordinary Shares is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-4.48. The reported EPS for the same quarter last year was $-21.59.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-4.48 | $-4.48 | $-4.48 | 1 |
| Dec 2026 | $-4.16 | $-4.16 | $-4.16 | 1 |
| Mar 2027 | $-1.92 | $-1.92 | $-1.92 | 1 |
| Jun 2027 | $-1.28 | $-1.28 | $-1.28 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · Fintel · Zacks · BNK Invest- RTTNews · Oct 29, 2:00 AM EDTEnlivex Randomizes 135 Patients In Phase 2b Knee Arthritis Trial; Data Due By Mid-2027(RTTNews) – Enlivex Ltd. (ENLV) said Wednesday it randomized 135 patients of a planned 182 patients in its Phase 2b trial of Allocetra for moderate-to-severe age-related symptomatic primary knee osteoarthritis.
- Fintel · Oct 28, 1:32 PM EDTEnlivex Therapeutics Ltd. Announces Randomization of 135 Patients in Phase 2b Trial of AllocetraEnlivex Therapeutics Ltd. announced that 135 patients, out of a total planned 182, have been randomized and were administered the first injection of AllocetraTM in the Company’s Phase 2b clinical trial of Allocetra™ for the treatment of patients with moderate-to-sever
- Fintel · Oct 27, 11:10 AM EDTEnlivex Therapeutics Ltd. Receives Nasdaq Delisting Notice and Announces 1-for-16 Reverse SplitEnlivex Therapeutics Ltd. announced that on October 26, 2026, the company received a delisting notification from the Listing Qualifications Department of The Nasdaq Stock Market Inc. stating that the closing bid price of the company's ordinary shares during the 30 consecutive bus
- RTTNews · Oct 23, 10:53 AM EDTWeekly Buzz: AZN, ALVO Score FDA Nod; EYPT Cuts Jobs; RHHBY, GEHC Enter Deal; VERA Posts Trial Win(RTTNews) – Healthcare and biotech news this week centred on regulatory approvals, strategic deals, and pivotal clinical data.
- Fintel · Oct 22, 10:58 PM EDTEnlivex Therapeutics Ltd. Announces 1-for-16 Reverse Share Split Effective October 27, 2026Enlivex Therapeutics Ltd. announced that its Board of Directors has determined to effect a reverse share split of its ordinary shares at a ratio of 1-for-16. The ordinary shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market on October 27, 2026, and wil
- RTTNews · Oct 19, 2:27 PM EDTEnlivex Announces Cost Cuts To Advance Allocetra Knee OA Trial; Stock Down(RTTNews) – Enlivex Ltd. (ENLV), a clinical-stage biotechnology company developing Allocetra for inflammatory conditions associated with aging, announced a cost reduction plan to substantially lower cash burn and focus resources on its Phase 2b trial evaluating Allocetra for mode
- Zacks · Sep 1, 9:55 AM EDTEnlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?Enlivex Ltd. (ENLV) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turna
- Zacks · Jul 13, 12:00 PM EDTEnlivex Ltd. (ENLV) Upgraded to Buy: Here's WhyEnlivex Ltd. (ENLV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- RTTNews · Jul 13, 10:41 AM EDTEnlivex's Allocetra Cell Therapy For Knee Osteoarthritis Gets FDA's RMAT Designation; Stock Down(RTTNews) – Enlivex Ltd. (ENLV), a biopharmaceutical company developing macrophage reprogramming therapies, announced on Monday that the U.S. FDA has granted Regenerative Medicine Advanced Therapy or RMAT designation to Allocetra for the treatment of age-related symptomatic knee
- Zacks · Jul 13, 9:35 AM EDTEnlivex Ltd. (ENLV) Loses 31.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerThe heavy selling pressure might have exhausted for Enlivex Ltd. (ENLV) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
- BNK Invest · Jul 10, 4:47 PM EDTRelative Strength Alert For EnlivexLegendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
- RTTNews · Jul 7, 9:15 AM EDTEnlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026; Stock Down(RTTNews) – Enlivex Ltd. (ENLV) will implement a 1-for-15 reverse stock split of its ordinary shares, effective July 9, 2026. Beginning that day, the company's share will trade on a split-adjusted basis on the Nasdaq Capital Market.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Enlivex Ltd. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.